29 Oct 2019 07:00
RNS Number : 4392R
Verseon Corporation
29 October 2019
October 29, 2019
Verseon Corporation
("Verseon" or the "Company")
Result of 2019 AGM
Fremont, Calif.-Verseon Corporation (AIM: VERS), a clinical-stage pharmaceutical company, announces that all resolutions put to shareholders during the Annual General Meeting ("AGM") held on October 28, 2019 at 9:00 am PDT were duly passed.
-Ends-
For further information, please contact
Verseon Corporation | www.verseon.com |
Sebastian Wykeham / Tina Schlafly | +1 (510) 225 9000 |
|
|
Arden Partners (NOMAD and Broker) |
|
Ruari McGirr / Ciaran Walsh / Dan Gee-Summons (Corporate Finance) / Fraser Marshall (Equity Sales) | +44 (0) 20 7614 5900 |
For trade and pharma media enquiries, please contact
Vane Percy & Roberts |
|
Simon Vane Percy | +44 (0) 1737 821 890 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
VERS.L (VERS)